Benzinga | Mar 11, 2021 08:41AM EST

Bellerophon Therapeutics Q4 EPS $(0.84) Up From $(0.89) YoY

Bellerophon Therapeutics (NASDAQ:BLPH) reported quarterly losses of $(0.84) per share. This is a 5.62 percent increase over losses of $(0.89) per share from the same period last year.